BIM
NVIV

Bogle Investment Management’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Bogle Investment Management’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-13
Closed -$4.01M – 485
2015
Q2 		$4.01M Buy
+13
New +$3.44M 0.3% 125

Other funds holding NVIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bogle Investment Management's NVIV Position: Q3 2015 in Review

Bogle Investment Management sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q3 2015, closing a stake of 13 shares — an estimated $4.01M sold.

Bogle Investment Management first reported a position in NVIV in Q2 2015 and held it in 1 quarter. The position peaked at $4.01M in Q2 2015. 37 funds tracked by Wall St. Rank hold NVIV as of Q3 2015.

  • Bogle Investment Management reported no remaining InVivo Therapeutics Holdings Corp position as of Q3 2015 after selling out during the quarter.
  • Bogle Investment Management sold 13 InVivo Therapeutics Holdings Corp shares in Q3 2015, an estimated $4.01M.
  • Bogle Investment Management first reported a position in InVivo Therapeutics Holdings Corp in Q2 2015 and held it in 1 quarter.
  • Bogle Investment Management's InVivo Therapeutics Holdings Corp position peaked at $4.01M in Q2 2015.
  • 37 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q3 2015.

Based on Bogle Investment Management's 13F filing for Q3 2015, filed 13 Nov 2015.